Health Care
股价
$340.61
+2.59%市值
$117B
今日最高
$341.83
今日最低
$332.15
Intuitive Surgical delivered strong Q2 FY2026 results with revenue up 18.5% YoY to $2,892.3M and operating income up 30.7% YoY to $971.9M, driven by continued da Vinci 5 adoption (installed base of 1,710 systems) and margin expansion despite ongoing tariff headwinds.
关键风险:Third-Party Remanufactured Instruments and Unauthorized Service
Regulatory authorities have cleared or approved remanufacturing of certain da Vinci instruments by third parties, and third parties have offered remanufactured/unauthorized instruments and unauthorized service on da Vinci and Ion systems, often at lower prices. This could reduce Intuitive's instrument and accessory revenue, create patient safety risks, and cause reputational harm if such products malfunction.
同属 Health Care Equipment 行业的其他公司